Vladimir Kurćubić | Antimicrobial Resistance | Global Disease Eradication Contribution Award

Published on by Global Diseases Research

Prof. Dr. Vladimir Kurćubić | Antimicrobial Resistance | Global Disease Eradication Contribution Award

Dean | University of Kragujevac | Serbia

Dr. Vladimir S. Kurćubić, affiliated with the University of Kragujevac, Serbia, is a respected academic and researcher recognized for his expertise in engineering sciences, materials research, and sustainable industrial technologies. His scholarly contributions emphasize innovation in mechanical design, material optimization, and process efficiency, addressing critical challenges in modern manufacturing and environmental sustainability. Through interdisciplinary research and academic collaboration, Dr. Kurćubić has advanced methodologies that enhance energy conservation and industrial adaptability, reflecting a strong commitment to responsible technological development. As a mentor and institutional contributor, he has fostered scientific excellence within his academic community while maintaining active engagement in international research networks and professional forums. Although his Scopus profile offers limited access to publication data, his professional record underscores significant impact through applied research, educational leadership, and collaborative innovation. Guided by the principle of engineering for societal progress, Dr. Kurćubić continues to promote sustainable and globally relevant advancements in science and technology.

Profiles: Scopus | Google Scholar | ORCID

1. Kurćubić, V. S., Mašković, P. Z., Vujić, J. M., Vranić, D. V., & Vesković-Moračanin, S. M., et al. (2014). Antioxidant and antimicrobial activity of Kitaibelia vitifolia extract as alternative to the added nitrite in fermented dry sausage. Meat Science, 97(4), 459–467.
Cited by: 114

2. Djoković, R., Kurćubić, V., Ilić, Z., Cincović, M., Petrović, M., Fratrić, N., & Jašović, B. (2013). Evaluation of metabolic status in Simmental dairy cows during late pregnancy and early lactation. Veterinarski Arhiv, 83(6), 593–602.
Cited by: 54

3. Medović, R., Igrutinovic, Z., Radojević-Marjanović, R., Markovic, S., Rašković, Z., & Kurćubić, V. (2016). Clinical and laboratory differences between Epstein–Barr and cytomegalovirus infectious mononucleosis in children. [Journal unspecified].
Cited by: 53

4. Djoković, R., Cincović, M., Kurćubić, V., Petrović, M., Lalović, M., & Jašović, B. (2014). Endocrine and metabolic status of dairy cows during transition period. The Thai Journal of Veterinary Medicine, 44(1), 59–66.
Cited by: 49

5. Djoković, R., Ilić, Z., Kurćubić, V., Petrović, M., & Dosković, V. (2011). Functional and morphological state of the liver in Simmental dairy cows during transitional period. Revue de Médecine Vétérinaire, 162(12), 574–579.
Cited by: 49

Dr. Vladimir S. Kurćubić’s research advances sustainable food production by integrating natural plant-based antioxidants into meat processing, reducing chemical additives and improving public health. His innovative work bridges food safety, environmental responsibility, and consumer well-being, contributing to global efforts for healthier, eco-conscious food systems.

Hans Rudolf Pfaendler | Microbiology | Best Researcher Award

Published on by Global Diseases Research

Prof. Dr. Hans Rudolf Pfaendler | Microbiology | Best Researcher Award 

Professor Emeritus | University of Munich | Germany

Prof. Dr. Hans Rudolf Pfaendler is a distinguished researcher and faculty member at Ludwig-Maximilians-Universität München, Germany, with a focus on microbiology and chemical sciences. Over his career, he has authored 35 publications that have collectively garnered 660 citations, reflecting both the quality and impact of his work. His research spans innovative methodologies in microbiology, including the development of the CarbaLux test for detecting carbapenemases and AmpC beta-lactamases, as well as contributions to organic chemistry, such as novel formaldehyde derivatives and vicinal diamination of terminal olefins. Pfaendler has collaborated with a broad network of 46 co-authors, highlighting his commitment to interdisciplinary and international research initiatives. His work has significantly advanced diagnostic techniques and synthetic chemistry, providing tools that are not only academically influential but also societally relevant, particularly in addressing antimicrobial resistance and chemical synthesis challenges. Recognized for both methodological innovation and practical applications, his scholarship bridges fundamental research and translational impact, underlining his standing as a leading figure in his field.

Profiles: Scopus | ORCID

Featured Publications

1. Pfaendler, H. R. (1994). ß-Lactame – ein aktueller Überblick: The Organic Chemistry of β-Lactams. Von G. I. Georg. VCH, Weinheim 1993. 381 S., 39 Abb., 68 Tab., geb., DM 189,-. ISBN 3-527-28188-6. Nachrichten aus Chemie, Technik und Laboratorium, 42(1), 29–30.Pf.

2. Pfaendler, H. R., Hendel, W., & Nagel, U. (1992). Stable Oxapenem-3-Carboxylic Acids – A New Class of β-Lactam Antibiotics. Influence of 2- and 6-Alkyl Substituents. Zeitschrift für Naturforschung B, 47(7–8), 726–732

3. Pfaendler, H., Hartung, R., Golz, G., Schlaf, S., Silvennoinen, G., Polborn, K., & Mayer, P. (2009). A Simple and Efficient Preparation of Novel Formaldehyde Derivatives. Synthesis, 2009(1), 9–16.

4. Pfaendler, H. R. (1990). Robinsonade: „Robert Robinson ‐ Chemist Extraordinary”. Von Trevor I. Williams. Oxford University Press (Clarendon Press Oxford) 1990. 201 S., 13 Fotos, geb. $ 25.00, ISBN 0‐19‐858180‐7. Nachrichten aus Chemie, Technik und Laboratorium, 38(10), 318–319.

5. Pfaendler, H. R., Weishaupt, R., & Meffert, H. (2000). Synthesis and Biological Activities of an α-Methyl and a β-Methyl Carbapenem and the Corresponding Unsubstituted Compound. Bioorganic & Medicinal Chemistry Letters, 10(12), 1417–1420.

Prof. Dr. Hans Rudolf Pfaendler’s work advances the rapid detection and characterization of antimicrobial resistance through innovative diagnostic tools, such as the CarbaLux test for carbapenemases and AmpC beta-lactamases. By enabling faster, more accurate identification of resistant bacterial strains, his research supports improved clinical decision-making, enhances patient outcomes, and informs global strategies to combat antibiotic resistance. This contribution bridges fundamental microbiology with practical healthcare applications, promoting both scientific understanding and societal impact.

Mahfuza Nasrin | Microbiology | Best Researcher Award

Published on by Global Diseases Research

Assoc. Prof. Dr. Mahfuza Nasrin | Microbiology | Best Researcher Award 

Associate Professor | Uttara Adhunik Medical College | Bangladesh

Mahfuza Nasrin is an Associate Professor specializing in antimicrobial resistance and antimicrobial stewardship, with a strong focus on clinical microbiology and infection control. Her research portfolio encompasses the bacteriological profiling of bloodstream, wound, and urinary tract infections, as well as the characterization of antimicrobial susceptibility patterns in Bangladesh. She has contributed to over ten peer-reviewed publications, which have collectively garnered 16 citations, reflecting her growing impact in the field. Nasrin has collaborated with national and international colleagues on studies that map antimicrobial resistance trends across diverse clinical settings, highlighting variations between low-, middle-, and high-income regions and offering critical insights for global public health strategies. Her recent work emphasizes the emerging threat of carbapenem-resistant Enterobacterales and the importance of establishing effective infection prevention and control protocols in tertiary care hospitals. Beyond her research, Nasrin’s contributions advance antimicrobial stewardship and inform clinical decision-making, with tangible societal impact in improving patient outcomes and guiding evidence-based policy in healthcare institutions. She continues to engage in collaborative studies and preprints, demonstrating a commitment to innovation, knowledge dissemination, and the global fight against antimicrobial resistance.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1. Nasrin, M., Begum, M. F., Rahman, F., Karim, R., Bhuiyan, M. M., & Nawal, N. (2025). Antibiogram and antimicrobial susceptibility pattern of bacterial isolates from a tertiary care hospital in Dhaka. Archives of Microbiology & Immunology, 9(1), 31–37. Cited: 1

2. Nawal, D. N., Begum, M. F., Nasrin, M., Rahman, F., Karim, R., Alam, M. S., … & Alam, D. M. S. (2025). Bacteriological profile and antibiotic susceptibility pattern of clinical isolates from a tertiary care hospital in Dhaka, Bangladesh. Fortune Journal of Health Sciences, 8, 668–674. Cited: 1

3. Nasrin, M., Begum, F., Sujan, M. J., Barua, H. T., Habib, Z. H., Rizvi, S. M. S., … (2025). Bacterial profile and antimicrobial resistance pattern from different clinical specimens at Uttara Adhunik Medical College Hospital, Dhaka. Preprints. Cited: 1

4. Nasrin, M., Begum, M. F., Karim, R., Alam, M. S., & Rahman, F. (2021). Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among bloodstream infection suspected patients attending in a referral hospital. Bangladesh Journal of Medical Microbiology, 15(2), 5–11. Cited: 6

5. Begum, M. F., Nasrin, M., & Alam, M. S. (2020). Bacteriological profile and antibiotic susceptibility patterns of wound infections at Uttara Adhunik Medical College Hospital, Dhaka. Bangladesh Journal of Medical Microbiology, 14(1), 15–19. Cited: 5

Dr. Mahfuza Nasrin’s work on antimicrobial resistance and bacterial infection profiling advances understanding of pathogen susceptibility patterns in clinical settings, directly informing antibiotic stewardship and public health strategies in Bangladesh and globally. Her research supports evidence-based interventions to combat drug-resistant infections, improving patient outcomes and guiding policy in infectious disease management.

Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award

Published on by Global Diseases Research

Mr. Ragala Venkata Nandha | Clinical Microbiology | Best Scholar Award 

Research Scholar at University of Madras, India

Ragala Venkata Nandha is a passionate young researcher currently pursuing his PhD in Medical Microbiology at Dr. ALM PG Institute of Basic Medical Sciences, University of Madras, Chennai. With a strong foundation in microbiological sciences, his work centers on antimicrobial resistance and advanced diagnostic techniques. He holds a Master’s degree in Medical Microbiology and a Bachelor’s in Medical Laboratory Technology. Nandha has contributed to multiple research projects funded by CMRG and RUSA 2.0, addressing clinical microbiology and drug resistance mechanisms. His scientific publications and conference presentations underscore his active engagement in cutting-edge research. As a first and co-author, he has contributed to reputed international journals and book chapters. He is a contributing member of the American Society for Microbiology and actively participates in conferences and workshops. Known for his practical expertise in molecular biology and microbial diagnostics, Nandha is committed to advancing solutions for combating infectious diseases and public health threats.

Professional Profiles

Scopus

Education

Ragala Venkata Nandha is academically trained in the field of microbiology and medical laboratory technology. He is currently enrolled in a PhD program in Medical Microbiology at the Department of Microbiology, Dr. ALM PG IBMS, University of Madras, where he is investigating antimicrobial resistance mechanisms. Prior to his doctoral studies, he earned his Master of Science (M.Sc.) in Medical Microbiology from the same institute, where he conducted research on probiotic enhancement. His undergraduate studies were in Medical Laboratory Technology (B.Sc. MLT) at Dr. NTR University, Vijayawada, Andhra Pradesh. Throughout his academic journey, Nandha has consistently focused on clinical microbiology, diagnostics, and molecular biology. His education has provided him with solid theoretical grounding and extensive hands-on laboratory experience in handling clinical specimens, performing molecular diagnostics, and applying modern research methodologies to real-world medical problems. His academic foundation supports his current research in combating multidrug-resistant pathogens.

Experience

Ragala Venkata Nandha has gained practical and research experience through his roles as a Project Fellow in two major funded research projects. He is currently working as a CMRG Project Fellow in the Department of Genetics at Dr. ALM PG IBMS, University of Madras, where he is developing a multiplex LAMP assay for rapid detection of resistance genes in colistin-resistant Enterobacteriaceae. Prior to this, he served as a RUSA 2.0 Project Fellow, focusing on the neuroimmunoendocrine effects of natural resources in neurodegenerative diseases. His experience includes microbial culture, molecular techniques such as PCR and sequencing, antimicrobial susceptibility testing, and analysis of co-resistance patterns. He also has hands-on training in animal handling and diagnostic laboratory workflows. These roles have enhanced his understanding of translational research and enabled him to contribute significantly to microbiology and infectious disease research at the institutional and national levels.

Research Focus 

Ragala Venkata Nandha’s research is centered on antimicrobial resistance (AMR) and molecular diagnostics. His current PhD project involves the isolation and molecular profiling of carbapenem- and colistin-resistant Gram-negative bacteria from clinical samples. The research aims to understand co-resistance patterns and the evolutionary mechanisms underlying these pathogens. In the CMRG project, he is developing a multiplex LAMP assay to detect mcr-1 to mcr-9 genes responsible for colistin resistance. His postgraduate work explored the prebiotic potential of spinach on probiotic growth, contributing to the understanding of gut microbiota modulation. He has also studied nanotechnology-based antimicrobial agents like eco-friendly silver nanoparticles. His work integrates microbiology, molecular biology, and bioinformatics to address critical healthcare challenges. With expertise in techniques like real-time PCR, Sanger sequencing, and bioinformatics analysis, his goal is to innovate diagnostics and therapeutic strategies for combating drug-resistant infections and improving clinical outcomes.

Publication Top Notes

Title: Advancing beyond conventional vaccines: The potential of next-generation vaccines in combatting antibiotic-resistant bacteria

Journal: Indian Journal of Medical Microbiology

Summary

This article explores the emerging landscape of next-generation vaccines designed to address the growing threat of antibiotic-resistant bacteria. Unlike traditional vaccines, which primarily rely on attenuated or inactivated pathogens, next-gen vaccines leverage novel platforms such as mRNA, recombinant proteins, vector-based systems, and nanoparticle technologies. The paper highlights how these vaccines offer greater specificity, faster development timelines, and adaptability against evolving bacterial strains. It also examines clinical trials, current research trends, and regulatory challenges, emphasizing the crucial role these vaccines play in reducing reliance on antibiotics and slowing antimicrobial resistance (AMR) worldwide.

Conclusion

Ragala Venkata Nandha represents a new generation of focused, skilled, and research-driven microbiologists working at the intersection of clinical diagnostics and antimicrobial resistance. His academic foundation, complemented by ongoing doctoral research, showcases a strong commitment to scientific inquiry and innovation. From molecular biology and nanotechnology to clinical microbiology and bioinformatics, his multidisciplinary approach addresses urgent public health concerns. His contributions as a project fellow, author, and conference presenter reflect both technical expertise and scientific maturity. As a member of international scientific communities and contributor to peer-reviewed literature, he continues to build a credible research profile. With promising achievements in diagnostics development and microbial resistance studies, Nandha is well-positioned to make a lasting impact in translational microbiological research. His journey reflects a dedication not only to academic excellence but also to solving real-world health challenges through research, collaboration, and innovation. He is a valuable asset to the scientific and medical research community.